News Flash Home
The original item was published from 8/19/2021 11:47:00 AM to 10/30/2021 12:05:02 AM.

News Flash


Posted on: August 19, 2021

[ARCHIVED] Monoclonal Antibody Infusion Treatment Center Coming to Volusia County

Ormond Beach — August 19, 2021 — Today, Governor Ron DeSantis announced that a state-run monoclonal antibody therapy treatment site for patients diagnosed with COVID-19 or considered high risk if infected has opened at the Ormond Beach Senior Center, 351 Andrews Street, Ormond Beach. The location will operate from 9 a.m. to 7 p.m. daily and is able to serve more than 300 patients per day. 

Walk-ins are welcome, but appointments are encouraged and can be made at 

The administered antibodies help the immune system recognize and respond effectively to the virus. According to treatment guidelines, they should be administered as soon as possible after diagnosis. By providing access to these treatments at these new sites, Governor DeSantis is alleviating demand on hospital resources and further making sure that Floridians have access to all potential treatments that can help them recover from COVID-19. 

Monoclonal antibody treatments can be prescribed by health care providers to individuals 12 years of age and older who have been diagnosed with COVID-19 or who have been exposed to someone with COVID-19 and are at high risk for severe illness and hospitalization. However, to support Governor DeSantis’ initiative, there is currently a standing order in Florida signed by the State Surgeon General that allows patients to receive this treatment without a prescription or referral if administered by an eligible health care provider. Such referrals are not required at any of the State of Florida monoclonal antibody treatment sites and treatments are available at no cost to patients. 

To find other locations offering monoclonal antibody treatments, visit 

DeSantis and the Florida Department of Health continue to encourage Floridians to receive the COVID-19 vaccine. 

To find a vaccine location, visit

Additional Info...
Facebook Twitter Email